A Single and Repeat Dose Trial in Participants With Hepatic Impairment

Clinical trial NCT05009680 · UNKNOWN

Trial details

NCT number: NCT05009680
Sponsor: Galecto Biotech AB
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2021-09-09
Primary completion: 2022-07-18
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.